BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6169674)

  • 1. Expression of the OKT monoclonal antibody defined antigenic determinants in malignancy.
    Greaves M; Delia D; Sutherland R; Rao J; Verbi W; Kemshead J; Hariri G; Goldstein G; Kung P
    Int J Immunopharmacol; 1981; 3(3):283-99. PubMed ID: 6169674
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoclonal antibody OKT-9 recognizes the receptor for transferrin on human acute lymphocytic leukemia cells.
    Goding JW; Burns GF
    J Immunol; 1981 Sep; 127(3):1256-8. PubMed ID: 6790617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human T cell differentiation antigens and correlation of their expression with various markers of T cell maturation.
    Boumsell L; Bernard A; Coppin H; Richard Y; Penit C; Rouget P; Lemerle J; Dausset J
    J Immunol; 1979 Nov; 123(5):2063-7. PubMed ID: 90700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunopathology of non-Hodgkin lymphomas.
    Huber H; Gattringer C; Knapp W; Stein H
    Klin Wochenschr; 1984 Nov; 62(21):1001-10. PubMed ID: 6392723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of human T lymphocytes: II. Phenotypic difference in skin and blood malignant T-cells in cutaneous T-cell lymphoma.
    Haynes BF; Hensley LL; Jegasothy BV
    J Invest Dermatol; 1982 Apr; 78(4):323-6. PubMed ID: 6121832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-surface structures involved in haemopoietic cell differentiation and proliferation.
    Greaves MF; Myers CD; Katz FE; Schneider C; Sutherland DR
    Br Med Bull; 1984 Jul; 40(3):224-8. PubMed ID: 6205712
    [No Abstract]   [Full Text] [Related]  

  • 7. Monoclonal antibodies against MHC class II antigens elicited with a human non-T, non-B acute lymphoblastic leukemia cell line.
    Poláková K; Chorváth B; Sedlák J; Duraj J; Matoska J; Karpatová M
    Neoplasma; 1985; 32(6):641-8. PubMed ID: 3911080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunologic phenotyping of cutaneous lymphomas].
    Kaudewitz P; Burg G; Smolle J; Braun-Falco O
    Hautarzt; 1986 Dec; 37(12):647-55. PubMed ID: 2880828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of soluble HLA class II antigenic material in patients with immunological diseases using monoclonal antibodies.
    Stevenson FK; George AJ; Walters MT; Hamblin TJ
    J Immunol Methods; 1986 Feb; 86(2):187-90. PubMed ID: 2418122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant lymphoma with dual B and T cell markers. Analysis of the neoplastic cells with monoclonal antibodies directed against T cell subsets.
    Aisenberg AC; Bloch KJ; Wilkes BM
    J Exp Med; 1981 Nov; 154(5):1709-14. PubMed ID: 6975352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and immunologic heterogeneity of Ia glycoproteins isolated from a chronic lymphocytic leukemia.
    Letarte M; Falk J
    J Immunol; 1982 Jan; 128(1):217-23. PubMed ID: 6976373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotype of cells involved in mycosis fungoides and Sézary syndrome (blood and skin lesions): immunomorphological study with monoclonal antibodies.
    Schmitt D; Souteyrand P; Brochier J; Czernielewski J; Thivolet J
    Acta Derm Venereol; 1982; 62(3):193-9. PubMed ID: 6179357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: II. Immunomorphological studies in blood and skin lesions.
    Schmitt D; Thivolet J
    J Clin Immunol; 1982 Jul; 2(3 Suppl):111S-119S. PubMed ID: 6982276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cells in the epidermotropic lymphomas (mycosis fungoides and Sézary syndrome. Study using monoclonal antibodies].
    Thivolet J; Schmitt D; Souteyrand P; Brochier J
    Nouv Presse Med; 1982 Oct; 11(41):3033-8. PubMed ID: 6755391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preference of the early murine immune response for polymorphic determinants on human lymphoid-leukemia cells and the potential use of monoclonal antibodies to these determinants in leukemia-typing panel.
    Maclean GD; Mosmann TR; Akabutu JJ; Longenecker BM
    Oncodev Biol Med; 1982; 3(2-3):223-32. PubMed ID: 6181486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [T-cell neoplasms with helper or suppressor activity].
    Rupniewska ZM
    Acta Haematol Pol; 1981; 12(1):53-61. PubMed ID: 6458988
    [No Abstract]   [Full Text] [Related]  

  • 17. A novel human T cell antigen preferentially expressed on mature T cells and shared by both well and poorly differentiated B cell leukemias and lymphomas.
    Kamoun M; Kadin ME; Martin PJ; Nettleton J; Hansen JA
    J Immunol; 1981 Sep; 127(3):987-91. PubMed ID: 6790625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of several cell surface proteins of non-T, non-B acute lymphoblastic leukemia by using monoclonal antibodies.
    Quackenbush EJ; Letarte M
    J Immunol; 1985 Feb; 134(2):1276-85. PubMed ID: 3155538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development and analysis of species specific and cross reactive monoclonal antibodies to leukocyte differentiation antigens and antigens of the major histocompatibility complex for use in the study of the immune system in cattle and other species.
    Davis WC; Marusic S; Lewin HA; Splitter GA; Perryman LE; McGuire TC; Gorham JR
    Vet Immunol Immunopathol; 1987 Jul; 15(4):337-76. PubMed ID: 3114940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic characterization of a T-CLL with heteroantisera and monoclonal antibodies: evidence for the T cell lineage of an Ia-positive, Fc-IgG--positive, suppressor-cell subpopulation.
    Strong DM; Pandolfi F; Slease RB; Budd JE; Woody JN
    J Immunol; 1981 Jun; 126(6):2205-8. PubMed ID: 6453158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.